logo
  

Moderna To Supply 20 Mln Doses Of Its COVID-19 Vaccine To Peru

Moderna Inc. (MRNA) announced a supply agreement with the government of Peru for 20 million doses of its COVID-19 vaccine to begin delivery in the first quarter of 2022.

The COVID-19 Vaccine Moderna is not currently approved for use in Peru, and the company will work with regulators to pursue necessary approvals prior to distribution.

The company said it is committed to making its vaccine available around the world as it seeks to address the pandemic with its COVID-19 vaccine.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
HSBC Holdings Plc shares were gaining In London trading as well as in pre-market activity on the NYSE after the Asia-focused lender backed its positive outlook after reporting significantly higher third-quarter profit. Further, the company announced share buyback of $2 billion, which will be commenced shortly. Walmart is recalling certain Aromatherapy Room Spray due to the possible presence of a rare and dangerous bacteria that is suspected to be behind two deaths in the United States, the U.S. Consumer Product Safety Commission said. The recall involves about 3,900 bottles of Better Homes and Gardens-branded Essential Oil Infused Aromatherapy Room Spray with Gemstones in six different scents. Royal Caribbean Group's ultra-luxury brand Silversea Cruises is set to launch the world's first hybrid-powered cruise ship in the summer of 2023. This will also be the first ship with large-scale fuel cell technology to enable emission-free port operations. The fuel cells will provide 100% of power while at port.
Follow RTT